|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 49/00 | |
| C07K 14/00 | |||
| C40B 50/00 | |||
| C40B 40/08 | |||
| C40B 40/02 | |||
| C40B 30/04 | |||
| C07H 21/00 | |||
| C12N 15/63 | |||
| C12N 1/21 | |||
| C12N 1/19 | |||
| C12N 5/10 | |||
| A61K 38/16 | |||
| A61P 25/00 | |||
| A61K 38/22 | |||
| A61P 7/00 | |||
| A61P 27/02 | |||
| A61P 35/00 | |||
| A61P 9/00 |
| (11) | Number of the document | 3103478 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16175500.4 |
| Date of filing the European patent application | 2011-04-29 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 329980 P | 2010-04-30 | US |
| (72) |
JACOBS, Steven, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |
| STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |